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Tularaemia, caused by Francisella tularensis, had not 
been registered in Kosovo* before an outbreak in 1999 
and 2000. A national surveillance system has been 
implemented in Kosovo* since 2000 to monitor a num-
ber of diseases, including tularaemia. Antibody detec-
tion in human sera was used for laboratory diagnosis 
of tularaemia and F. tularensis lipopolysaccharide anti-
gen was used as a marker of infection. The purpose 
of this study is to describe the incidence of tularae-
mia in Kosovo* after the 1999–00 outbreak. In 2001 
and 2002, a second outbreak occurred, with 327 sero-
logically confirmed cases. From 2001 to 2010, 25–327 
cases were registered per year, giving a mean annual 
incidence of 5.2 per 100,000 population. The most 
likely sources of infection were contaminated drinking 
water and food. The dominant clinical manifestations 
were the glandular (79%) and ulcero-glandular (21%) 
forms. By 2010, the disease had spread throughout 
Kosovo*. Presumably as a result of war and subse-
quent environmental disruption, mass population dis-
placement and breakdown of sanitation and hygiene, 
the two major outbreaks of tularaemia resulted in the 
establishment of an active endemic area of tularaemia 
in Kosovo*.
Introduction
The causative agent of tularaemia, a relatively rare 
zoonotic disease, is Francisella tularensis. The bacte-
rium is widely distributed in the northern hemisphere 
and is found in Europe [1]. Most countries in central 
and southern Europe reported single cases over the 
past decades. The disease is a more serious public 
health problem in Balkan countries and has also been 
reported in Turkey [2-4]. 
The cells of this Gram-negative, non-motile, capsule-
forming, facultative intracellular bacterium are pleo-
morphic, typically appearing as short rods or coccoid 
forms [5]. Two subspecies of F. tularensis cause tularae-
mia in man. Biovar A1 of the subspecies tularensis (or 
type A) is the most virulent type of Francisella bacteria 
and can be associated with lethal pulmonary infec-
tions in humans [6]. Subspecies holarctica (or type B) is 
assumed to be less virulent. F. tularensis ssp. tularensis 
has been isolated almost exclusively in North America, 
whereas F. tularensis ssp. holarctica could be found 
in the entire northern hemisphere [5]. Interestingly, a 
second biovar of F. tularensis ssp. tularensis, A2, has 
a lower morbidity and mortality in humans than ssp. 
holarctica [6]. 
Depending on the site of entry of the pathogen, tularae-
mia can occur as ulcero-glandular and glandular forms, 
as well as oculo-glandular, oropharyngeal, respiratory 
or typhoidal [5]. Humans acquire the bacterium through 
contact with infected animals and/or vectors, by inhal-
ing contaminated dust or aerosols, or by consumption 
of contaminated food or water. Human-to-human trans-
mission is unlikely [5]. 
Francisella is capable of infecting a large number of 
animal species such as hares, rabbits, mice, lemmings 
and even fish [5]. Birds are known to be carriers, but 
probably do not develop the disease themselves [5]. 
Various vectors could play a role in transmission of 
F. tularensis from animals to humans: in Scandinavia, 
mosquitoes probably play a major role, while in North 
America, ticks are considered to be the most important 
vector [5].
F. tularensis is able to survive in the environment under 
cool and humid conditions, probably for weeks, and 
has been found in water and soil [7]. The mechanisms 
for survival of the bacteria are not yet well understood. 
Protozoa and nutrient conditions could play a role in 
protecting the bacteria [8-10]. 
History shows that tularaemia outbreaks are asso-
ciated with poor hygienic conditions, especially in 
war and post-war situations, accompanied by a large 
increase in rodent populations and subsequent mass 
death of these animals [1,11-13]. Natural outbreaks 
occur in various endemic areas and can involve several 
hundred patients [1]. F. tularensis has been listed as a 
potential biowarfare agent [13,14]. 
Tularaemia had not been recorded in Kosovo* until an 
outbreak of the disease in 1999–2000 [13,15]. An inten-
sive case investigation was carried out during the first 
outbreak [15]: specific antibodies against F. tularensis 
were detected in 247 serum samples from 912 sus-
pected cases. Kosovo*, in south-east Europe, covers an 
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area of 10,908 km2, with a population of approximately 
2.1 million inhabitants and population density of 192 
per km2. It proclaimed its independence in 2008.
In January 2000, the national Institute of Public 
Health in Pristina implemented a surveillance system 
for 20 communicable diseases, based on syndromic 
approaches and clinical diagnoses. Timely reporting 
of disease syndromes from the different municipalities 
(administrative regions) allows a number of the most 
important infectious diseases in Kosovo* to be moni-
tored simultaneously.
This study aims to provide a follow-up on the incidence 
of tularaemia in Kosovo* after the first outbreak in 
1999–00 until 2010. 
Methods
Case definition
A suspected case of tularaemia was defined as a per-
son with fever and enlargement of cervical lymph 
nodes. The following indicators could also be present: 
skin ulcers and perspiration; weakness, body pain 
and headache; and throat pain and ingestion prob-
lems. Confirmed cases were individuals with the above 
clinical picture in whom laboratory confirmation of the 
infection was obtained.
To ensure that all individuals with the tularaemia were 
identified, the case definition was rather broad. The 
clinical manifestation of F. tularensis infection can 
be quite similar to that of tuberculosis, brucellosis or 
mumps – all of these diseases have a relatively high 
prevalence and incidence in Kosovo* (data not shown). 
Therefore, laboratory conformation by detecting spe-
cific antibodies or the pathogen itself is required for 
the final diagnosis of tularaemia. 
Collection of epidemiological data
All outpatient clinics and medical centres are obliged 
to fill in official reporting forms every week to record 
aggregated and individual data on the 20 specified 
communicable diseases, including tularaemia. The 
forms are sent to the regional Institute of Public Health, 
which subsequently passes them on to the national 
institute. Double reporting is prevented by checking 
the personal data of reported cases. At the national 
institute, the data are entered into a central database, 
to be regularly analysed by means of Epi-Info software. 
Diagnostic sera were obtained by local physicians from 
suspected cases and sent for analysis to the national 
Institute of Public Health. The sera were analysed for 
specific antibodies to F. tularensis, routinely using a 
microagglutination assay [16]. Positive sera and addi-
tional sera from persons suspected to be infected with 
F. tularensis were checked by a highly specific enzyme-
linked immunosorbent assay (ELISA) and western blot 
analysis, as described below.
Microagglutination
The live vaccine strain of F. tularensis biovar holarc-
tica (ATCC 29648) was grown for 2–3 days at 37 °C in 
a 5% CO2 humid atmosphere on heart-cysteine-blood 
agar and harvested into sterile distilled water or iso-
tonic sodium chloride. Bacterial concentrations were 
adjusted photometrically at 580 nm to an optical den-
sity of 1.0. The suspension was inactivated with para-
formaldehyde and prepared as agglutination antigen 
as described elsewhere [16]. The assay was adjusted 
by the optimal antigen concentration and evaluated on 
the basis of a titre of 1:16 or higher being considered 
positive. 
Antibody detection in human sera 
by ELISA and western blot
The ELISA was used for screening and western blot for 
confirmation. Both have been described elsewhere [16-
18] and were used with some modifications. Briefly, a 
96-well microtitre plate (Polysorb, Nunc, Germany) was 
coated with purified lipopolysaccharide (LPS) from the 
live vaccine strain as antigen. Bound human antibod-
ies to F. tularensis were detected by polyvalent goat 
anti-human IgA-IgM-IgG horseradish peroxidase-con-
jugated secondary antibody (dianova, Germany) and 
subsequent substrate reaction. For the western blot, 
the soluble fraction of formalin-inactivated live vaccine 
strain was separated using sodium dodecylsulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and 
then transferred to polyvinylidene difluoride (PVDF) 
membranes (ImmobilonP, Millipore, United States). 
Using polyvalent horseradish peroxidase-conjugated 
secondary antibodies, the typical LPS ladder revealed 
the presence of specific anti-F. tularensis antibodies. 
The final results were given after confirmation of the 
ELISA results by western blot: ‘positive’ denoted strong 
bands, ‘negative’ – almost no bands and ‘borderline’ – 
weak but clearly visible bands). 
Samples for antigen detection 
and capture ELISA
Environmental samples (faeces from rabbits and mice, 
water samples), tissue samples (spleen, liver) from 
dead mice, rats and rabbits, as well as clinical samples 
from serologically confirmed tularaemia patients were 
analysed using a capture ELISA. It was essentially per-
formed as described previously, using the F. tularen-
sis LPS-specific murine monoclonal antibody 11/1/6 as 
capture antibody bound to the solid phase [19-21].
Faeces from pathogen-free inbred and outbred mice 
and rabbits were kindly provided by the National 
Research Centre for Environment and Health (GSF) in 
Munich, Germany, which were used as negative con-
trols. Samples were homogenised and pre-treated with 
LPS-extraction buffer containing chenodeoxycholic 
acid in phosphate buffered saline/ethylenediaminetet-
raacetic acid (PBS/EDTA). Large particles were allowed 
to sediment for 5 minutes and the supernatant was 




Tularaemia outbreak in 2001 and 2002
After the tularaemia outbreak in 1999–00, a sec-
ond outbreak occurred from November 2001 to June 
2002, which was investigated by a Kosovar/German 
team from the Bundeswehr Institute of Microbiology, 
Munich, Germany. This outbreak has not been previ-
ously described in the scientific literature. During this 
period, 1,168 serum samples from suspected cases 
were tested; 327 cases laboratory confirmed by ELISA 
and western blot (Figure 1). Although the second out-
break started in other parts of Kosovo* (east and 
south-east), the affected areas generally overlapped 
those of the previous outbreak. 
The epidemiology of the second outbreak was quite 
similar to that of the first [15]. It can be assumed that 
the main reason for the spread of the disease seemed 
to be again the bad sanitary conditions, especially in 
rural areas of Kosovo*.  As described for the first out-
break [15], housewives (37%) and farmers (27%) were 
the most affected occupational groups.  Similarly, 
cases were mainly female (60%) and the age group 
20–40 years (52%) were also most affected. 
It was characteristic of both outbreaks that people in 
affected regions reported an enormous increase in the 
rodent population, especially field, forest and domes-
tic mice before the outbreak among humans. 
The investigation of animal and environmental speci-
mens by the capture ELISA, which is highly specific for 
F. tularensis [19], showed that the antigen was detected 
mainly in mouse and hare faeces (Table). During the 
outbreaks, faeces of small rodents were regularly 
found by the investigation teams in products stored 
in food stores of affected households and showed the 
most striking positive results in antigen detection of 
F. tularensis. During the first and second outbreaks, 
145 and 220 samples were collected respectively from 
similar sources, of which 10 and 22, respectively, were 
positive. We could not detect F. tularensis antigen in 
a very limited number of available clinical specimens: 
throat swabs (n=18), pus and wound secretions (n=4). 
At that time, a more sensitive polymerase chain reac-
tion (PCR) was not available.
As in the first outbreak, the predominant manifestation 
of the disease during the second was oropharyngeal. 
The main route of transmission leading to this oro-
pharyngeal form was probably ingestion of contami-
nated food or water [15]. More than 90% of the patients 
(305/327) had as the leading symptom enlarged cer-
vical lymph nodes, whereas the other patients had 
enlarged lymph nodes in other locations such the 
axilla or inguinal region. This clinical manifestation of 
oropharyngeal tularaemia was dominant throughout 
the study period.
Figure 1 








633  658  
725  
810  

























Cumulative number of cases
*  This designation is without prejudice to positions on status, and is in line with United Nations Security Council Resolution 1244/99 and the 
International Court of Justice Opinion on the Kosovo declaration of independence.
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Surveillance of tularaemia from 2001 to 2010
After the first outbreak, the surveillance system 
revealed the presence of cases every year (Figure 1). 
From 2003 to 2010, the annual number of tularaemia 
cases was between 25 and 237, with a mean annual 
incidence of 3.9 ±3.2 standard deviation (SD) per 
100,000 population. During this period, a total of 647 
cases were reported. 
In 2010, more than 200 tularaemia cases were reg-
istered. The reason for this high number of cases is 
unknown: no specific source of infection nor a specific 
outbreak scenario could be identified. The cases were 
distributed equally throughout Kosovo* and through-
out the year. This could indicate a high epizootic 
and zoonotic activity in that year, for some unknown 
reason.
Housewives and farmers were the most affected occu-
pational groups, representing about 33% (n=216) 
and 24% (n=153) of cases, respectively. This is also 
reflected in the sex distribution of all cases during this 
period: 57% (n=372) of cases were female and 43% 
male (n=275) (Figure 2). Most cases (n=309) were in 
the age group 20–40 years, of whom 61% (n=188) were 
female and 39% (n=121) male. In addition, quite a high 
proportion, about 20% (n=128) of children and teenag-
ers (aged under 20 years) were infected. 
Since 2001, the clinical manifestation in the 974 
patients was oropharyngeal or glandular tularae-
mia: about 93% (n=906) of the cases had unilaterally 
enlarged cervical lymph nodes or swollen axillar or 
inguinal lymph nodes; 7% (n=67) had the ulcero-glan-
dular form. 
Since the first outbreak, tularaemia has spread to other 
parts of Kosovo*. As a result, all municipalities partici-
pating in the surveillance system have reported human 
tularaemia cases (Figure 3). The three municipalities 
marked in grey in Figure 3B were not participating in 
the surveillance system. 
Discussion
By mid-1999, more than 10 years of political crisis 
and warfare in Kosovo* had resulted in environmen-
tal disruption, mass population displacement and a 
breakdown of sanitation and hygiene [15]. Many essen-
tial public health functions, such as disease surveil-
lance and outbreak response, had collapsed [15]. It 
Table
Francisella tularensis antigen detection in animal and environmental specimens during tularaemia outbreaks in Kosovo*, 
1999–2002 (n=365)
Sample type Source














Mice 55 7 58 9 113 16
Control: pathogen-free mice NT NT 100 0 – –
Hares NT NT 104 12 104 12
Control: pathogen-free rabbits NT NT 57 0 – –
Animal tissue
Mice, rats, hares 63 3 35 1 98 4
Control: pathogen-free mice NT NT 25 0 – –
Water Wells, ponds 27 0 23 0 50 0
Total without controls – 145 10 220 22 365 32
NT: not tested.
* This designation is without prejudice to positions on status, and is in line with United Nations Security Council Resolution 1244/99 and the 
International Court of Justice Opinion on the Kosovo declaration of independence.
Figure 2 
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is suspected that tularaemia had been present in the 
region during and/or after the Second World War, but 
there are no official data about the disease in Kosovo* 
during that time. Although the disease was notifiable 
in the former Yugoslavia, local representatives stated 
that no cases of tularaemia had been detected before 
the war in Kosovo* in 1998 to 1999 [13]. 
The number of laboratory-confirmed cases of tularae-
mia in the first outbreak in 1999–00 was unexpectedly 
high, given that Kosovo* had been considered non-
endemic for the disease at that time. An even larger 
number of cases was seen during the second outbreak 
in 2001–02. The circumstances of a typical post-war 
situation in the autumn of 1999 were probably respon-
sible for the outbreaks: people left their homes and 
did not harvest the fields, which led to an oversupply 
of food for rodents [13]. Consequently, an unusually 
large increase in the rodent population was observed 
until January 2000. It is known that an increased den-
sity of the rodent population can facilitate the spread 
of zoonotic infectious pathogens including F. tularen-
sis among animals and induce an epizootic spread to 
man [22]. We found F. tularensis antigen in a relatively 
high percentage of samples from collected rodents 
and hares. However, for further identification of the 
infectious source and characterisation of the causative 
agent, attempts should still be made to obtain isolates 
of F. tularensis from the samples collected between 
1999 and 2002. 
As almost all the tularaemia patients during 2001 to 
2010, as in the first outbreak [15], had the oropharyn-
geal form with fever and a unilateral cervical lymph 
node enlargement as the main symptoms, obviously 
the main route of infection was alimentary ingestion 
of F. tularensis. It was rather surprising that during the 
first outbreak, cases were spread over a large part of 
Kosovo*. It can be speculated that either the pathogen 
had already been present in these regions in spite of 
not having been observed or it was spread by human 
and animal migration as a consequence of the war. It 
was assumed by the national Institute of Public Health 
and the outbreak investigation team at that time that 
an emerging or re-emerging endemic region with peri-
odic outbreaks of tularaemia might develop in Kosovo*. 
In fact, the data for 2003 to 2010 indicate a continuous 
activity of tularaemia after the initial outbreaks. 
The clinical manifestation in 2010 was similar to 
that during the outbreaks in 1999–2002, which sug-
gests that the routes of transmission have remained 
the same. In comparison, in other parts of the world, 
the ulcero-glandular form of tularaemia is primarily 
detected, which can arise due to direct exposure of the 
patients’ skin to infected animals, carcasses, water or 
other materials, or to arthropod vectors [1,5]. Climate 
change is believed to influence the spread of vectors 
and therefore of tularaemia [23]. Obviously alimentary 
ingestion of the pathogen has been the major route 
of infection in Kosovo*. Given the situation, ingestion 
of contaminated food and water arising from the poor 
hygiene conditions seem to be the most likely risk fac-
tors for the infection. 
Interestingly, the mean incidence of tularaemia in 
Kosovo* from 2001 to 2010 (5.2±4.6 SD per 100,000 
population) is comparable to that in Sweden (3.2±2.08 
SD per 100,000 population, calculated for the same 
time period from data from the Swedish Institute for 
Communicable Disease Control [24]), which is known to 
be endemic for tularaemia, and about 100 times higher 
than that in Germany (0.013±0.012 SD per 100,000 
population; calculated for the same time period 
from SurvStat data from the Robert Koch Institute in 
Germany [25]). Tularaemia in Germany is less evident 
than in some other countries, but little is known about 
the epizootic activity of the disease in Germany. Thus, 
low numbers of reported human cases in Germany may 
not reflect the actual prevalence of the pathogen in 
nature and the potential risk of epidemics [26]. 
In 2010, Kosovo* represented an emergent endemic 
region for tularaemia. The reasons for this develop-
ment are not fully understood. More recent data are in 
the process of being evaluated at the national Institute 
of Public Health in Pristina. Further surveillance of this 
disease is important in order to detect possible out-
breaks in a timely manner and to take adequate meas-
ures to prevent the further spread of the disease. The 
main reason for ongoing activity of the disease seems 
to be the still poor sanitary conditions, especially in 
rural areas of Kosovo*. In addition, animal control 
and surveillance, including that of rodents, should 
be carried out to prevent further outbreaks. Further 
field investigation is required to obtain Francisella iso-
lates for clarification of the subspecies prevalent in 
Kosovo* and to further identify reservoirs and routes 
of transmission of the pathogen. Additional resources 
are required to manage this serious health problem, 
although other infectious diseases may have an even 
higher impact on public health in Kosovo*. 
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